Cigna Corporation

NYSE:CI

Medical - Healthcare Plans

Healthcare
$285.37 -1.56%

-$4.44 today

Market cap
$75.20B
Beta
0.30
P/E (TTM)
11.7
EPS (TTM)
$23.95
Dividend yield
2.19%
52W Low $239.51High $338.89

Volume 2.49M

Average 1.61M

CI Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Cigna CorporationNYSE: CI

Accounts Payables · Q3 FY2026 · quarter ended Sep 2026

Accounts payables turns negative

Q3 FY2026 accounts payables was -$334M, compared with $163M a year earlier. Trailing-twelve-month accounts payables was $3.55B. Over 3 fiscal years it compounded at +17.3% a year.

Context

  • Accounts payables amounted to 1.0% of revenue in FY2025, up 0.6 pp from a year earlier.
  • Accounts payables increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly accounts payables holds near -$334M or moves back toward the trailing-twelve-month quarterly average of $887.5M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$334M-127.4% QoQ
Last fiscal yearDec 2025
$2.8B+145.8% YoY
LTMSep 2026
$3.55B+304.3% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-304.9%——
1 year+145.8%——
3-year CAGR+17.3%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
2.8B USD
Year-over-year change
+145.8%
4-year CAGR
+8.2%

Accounts Payables vs competitors

How CI compares with its peers on the latest reported figures

  • CI's LTM Sep 2026 accounts payables of $3.55B is the 3rd largest of the 9 companies compared; the peer median is $34.13M.
  • Its year-over-year change of +304.3% is the 2nd highest of 9, against a peer median of -70.4%.
  • Accounts payables amounts to 1.2% of revenue for CI, versus a peer median of 0.4%.
CI Competitors Peer median
Accounts Payables for CI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CNCCentene CorporationLTM Jun 2026$6.37B +332.8%—3.3%
UNHUnitedHealth Group IncorporatedLTM Sep 2026$6.18B -183.6%—1.4%
CICigna CorporationLTM Sep 2026$3.55B +304.3%+17.3%1.2%
ELVElevance Health Inc.LTM Sep 2026$1.02B -400.6%—0.5%
CVSCVS Health CorporationLTM Jun 2026$947M -80.8%-3.3%0.2%
HUMHumana Inc.LTM Sep 2026$121M -88.3%—0.1%
OSCROscar Health, Inc.LTM Jun 2026$74.49M -60.0%-15.7%0.5%
MOHMolina Healthcare, Inc.LTM Sep 2026$62M +231.9%—0.1%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$6.26M +69.2%—0.1%
Peer median (excluding CI) $34.13M-70.4%-9.5%0.4%

Competitors are the stored peer set for CI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income5.42B6.78B5.37B3.78B6.29B
Depreciation & Amortization2.92B2.94B3.04B2.78B2.78B
Deferred Income Tax(216M)(472M)(1.66B)(95M)326M
Stock-Based Compensation00000
Change in Working Capital(879M)259M3.03B418M(261M)
Accounts Receivables(3.5B)(2.24B)(1.66B)(7.37B)(4.63B)
Inventory(557M)(1.06B)(868M)(1.03B)(646M)
Accounts Payables2.04B1.73B3.48B1.14B2.8B
Other Working Capital1.14B1.82B2.08B7.68B2.22B
Other Non-Cash Items(57M)(850M)2.04B3.49B473M
Operating Cash Flow7.19B8.66B11.81B10.36B9.6B
Capital Expenditures(1.15B)(1.3B)(1.57B)(1.41B)(1.21B)
Acquisitions (Net)(1.89B)4.84B(434M)390M2.39B
Purchases of Investments(6.11B)(4.32B)(5.54B)(2.7B)(7.2B)
Sales of Investments5.59B4.11B2.64B2.45B2.65B
Other Investing Activities(50M)(233M)(264M)(838M)(1.03B)
Investing Cash Flow(3.61B)3.1B(5.17B)(2.1B)(4.41B)
Debt Repayment657M(2.56B)(278M)1.06B(666M)
Common Stock Issued326M389M187M305M203M
Common Stock Repurchased(7.74B)(7.61B)(2.28B)(7.03B)(3.62B)
Dividends Paid(1.34B)(1.38B)(1.45B)(1.57B)(1.61B)
Other Financing Activities(112M)(79M)(469M)(411M)(726M)
Financing Cash Flow(8.21B)(11.24B)(4.29B)(7.65B)(6.42B)
Effect of Forex Changes(65M)(86M)16M(20M)1.35B
Net Change in Cash(4.7B)428M2.36B594M126M
Free Cash Flow6.04B7.36B10.24B8.96B8.39B

Cigna Corporation

NYSE:CI

Intrinsic Alpha fair value

Locked

Current Price

$285.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.